title: [Follicular lymphoma with paraneoplastic autoimmune multiorgan syndrome].
authors.forename: I
authors.initials: I
authors.lastname: Hidalgo
authors.forename: F
authors.initials: F
authors.lastname: Martinez
authors.forename: C
authors.initials: C
authors.lastname: Grau
authors.forename: I
authors.initials: I
authors.lastname: Gil
authors.forename: A
authors.initials: A
authors.lastname: Azón
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000209:etiology*; D002613:Cheilitis / Q000209:etiology; D003231:Conjunctivitis / Q000209:etiology; D003320:Corneal Ulcer / Q000209:etiology; D003520:Cyclophosphamide / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005928:Glossitis / Q000209:etiology; D006801:Humans; D015603:Keratinocytes / Q000473:pathology; D007642:Keratosis / Q000209:etiology; D008224:Lymphoma, Follicular / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000209:etiology*; D010392:Pemphigus / Q000175:diagnosis / Q000209:etiology*; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D000069283:Rituximab; D012883:Skin Ulcer / Q000209:etiology; D020521:Stroke / Q000150:complications; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D016572:Cyclosporine; D003520:Cyclophosphamide; D011241:Prednisone; D008775:Methylprednisolone